| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 224 | 174 | +28.8% |
| EBITDA | 92.1 | 78.8 | +16.9% |
| EBITDA margin | 41.0% | 45.2% | −4.2 pts |
| Profit before tax | 87.5 | 68.5 | +27.8% |
| Net profit | 65.9 | 51.3 | +28.5% |
| EPS | ₹5.30 | ₹4.13 | +28.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 4,293 | — | — | |
| 111 | 111 | — | |
| −0.1 | −0.1 | — | |
| 0.5 | 0.5 | — | |
| 4,182 | — | — | |
| 851 | 801 | — | |
| 363 | 349 | — | |
| 42.6% | 43.6% | — | |
| 309 | 302 | — | |
| 236 | 222 | — | |
| 27.8% | 27.7% | — | |
| ₹19.01 | ₹17.85 | — | |
| — | 254 | — | |
| — | −34.1 | −41.8 | |
| 220 | 220 | — | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 4,292.7 | |
| - Cash, Equiv & ST Investments | — | 111.5 | 111.5 | |
| + Minority Interest | — | -0.1 | -0.1 | |
| + Total Debt | — | 0.5 | 0.5 | |
| Enterprise Value | — | — | 4,181.5 | |
| Revenue | — | 801.4 | 851.5 | |
| EBITDA | — | 349.4 | 362.7 | |
| Margin % | — | 43.60 | 42.60 | |
| EBIT | — | 301.7 | 309.3 | |
| Net Income | — | 221.7 | 236.3 | |
| Margin % | — | 27.67 | 27.75 | |
| EPS, Adj (current shares) | — | 17.85 | 19.01 | |
| Cash from Operations | — | 253.8 | — | |
| Capital Expenditures | -41.8 | -34.1 | — | |
| Free Cash Flow | — | 219.7 | 219.7 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Jeena Sikho Lifecare (NSE: JSLL) had a market capitalisation of ₹4,323 crore at the 29 October 2026 close (₹347.75 a share), a PE ratio of 18.3 on the last four quarters' profit and a price-to-book ratio of 9.25. In FY26 its consolidated net profit was ₹222 crore on revenue of ₹801 crore; in Q1 FY27 (April–June 2026) it was ₹65.9 crore, up 28.6% year on year. Its debt-to-equity ratio was 0.00 on 31 March 2026. Promoters held 63.67% of the shares on 30 September 2026.
Jeena Sikho Lifecare's PE ratio is 18.3 at the 29 October 2026 close (₹347.75 a share): a market capitalisation of ₹4,323 crore divided by consolidated net profit of ₹236 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹222 crore) it is 19.5.
Jeena Sikho Lifecare's price-to-book (PB) ratio is 9.25 at the 29 October 2026 close: a market capitalisation of ₹4,323 crore divided by shareholders' equity (book value) of ₹467 crore on 31 March 2026. That is a book value of ₹37.58 per share against a share price of ₹347.75.
Jeena Sikho Lifecare's dividend yield is 1.29% at the 29 October 2026 close: dividends of ₹4.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹347.75. They were ₹4.50 on 21 September 2026.
Jeena Sikho Lifecare's market capitalisation was ₹4,323 crore at the 29 October 2026 close: 12.43 crore shares at ₹347.75 each.
Jeena Sikho Lifecare's basic earnings per share (EPS) were ₹17.84 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹19.02.
In 2026, Jeena Sikho Lifecare has declared one dividend: ₹4.50 with record date 21 September 2026.
No. Jeena Sikho Lifecare had borrowings of ₹45 lakh on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.00. Its cash and current investments were ₹204 crore, so it held net cash of ₹203 crore.
Jeena Sikho Lifecare's debt-to-equity ratio was 0.00 on 31 March 2026: borrowings of ₹45 lakh against total equity of ₹467 crore.
In FY26 (April 2025–March 2026), Jeena Sikho Lifecare's consolidated net profit was ₹222 crore, on revenue from operations of ₹801 crore.
Jeena Sikho Lifecare's net worth — shareholders' equity in its consolidated balance sheet — was ₹467 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹4,323 crore at the 29 October 2026 close.
Jeena Sikho Lifecare's book value per share was ₹37.58 on 31 March 2026: shareholders' equity of ₹467 crore divided by the 12.43 crore shares in issue. The share price at the 29 October 2026 close was ₹347.75.
In FY26, Jeena Sikho Lifecare generated ₹254 crore of cash from operations and spent ₹34.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹220 crore.
Promoters held 63.67% of Jeena Sikho Lifecare on 30 September 2026, up 0.05 percentage points from 63.62% the previous quarter and up 0.06 percentage points from 63.61% a year earlier, according to the shareholding pattern filed with NSE.
Jeena Sikho Lifecare's latest results are for Q1 FY27 (April–June 2026): consolidated net profit ₹65.9 crore, up 28.6% from ₹51.3 crore in Q1 FY26; revenue from operations ₹224 crore, up 28.8% year on year.
On FY26 consolidated figures, against Le Travenues Technology and Inox Green Energy Services: Jeena Sikho Lifecare's operating margin of 37.7% is the highest of the three (Le Travenues Technology 4.7%, Inox Green Energy Services 7.6%; peer average 6.2%).
On 30 September 2026, Jeena Sikho Lifecare's shares were held by promoters 63.67%, foreign portfolio investors (FII/FPI) 4.50%, domestic institutions (DII) 0.53% (including mutual funds at 0.10%) and retail and other non-institutional investors 31.30%. Over the year, FII holding was down 2.09 percentage points from 6.59% and DII holding was up 0.38 percentage points from 0.15%.
At the 29 October 2026 closing prices, on FY26 net profit, Jeena Sikho Lifecare's PE ratio is 19.5, the lowest of the three: Le Travenues Technology 86.9 and Inox Green Energy Services 41.9, a peer average of 64.4. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Jeena Sikho Lifecare earned net profit of ₹222 crore on revenue of ₹801 crore, against ₹72.1 crore on ₹1,228 crore for Le Travenues Technology. Jeena Sikho Lifecare's operating margin was 37.7% (Le Travenues Technology 4.7%). At the 29 October 2026 close, Jeena Sikho Lifecare's market capitalisation was ₹4,323 crore against ₹6,266 crore for Le Travenues Technology, and its PE ratio on FY26 profit 19.5 against 86.9.
Jeena Sikho Lifecare has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
From Jeena Sikho Lifecare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.